The ●●●●●●r order ●●●●●●el from ●●●●●● The ●●●●●●ers, whose ●●●●●●ns were ●●●●●● on Monday on the FDA's ●●●●●●e, said the nasal spray, which ●●●●●●tly ●●●●●●es a ●●●●●●●●●●●● for use, "has a ●●●●●●ble risk-●●●●●●t ●●●●●●e" for use in an over-the-●●●●●●r ●●●●●●g.
